The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-epi-16-deoxysarcophine ID: ALA560225
Max Phase: Preclinical
Molecular Formula: C20H30O2
Molecular Weight: 302.46
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC1=C2CC/C(C)=C/CC[C@]3(C)O[C@H]3CC/C(C)=C\[C@H]2OC1
Standard InChI: InChI=1S/C20H30O2/c1-14-6-5-11-20(4)19(22-20)10-8-15(2)12-18-17(9-7-14)16(3)13-21-18/h6,12,18-19H,5,7-11,13H2,1-4H3/b14-6+,15-12-/t18-,19+,20+/m1/s1
Standard InChI Key: OQGXDKRHMBRZCS-CAPKMUHJSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
7.2343 -26.6661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5439 -26.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6665 -25.4045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9074 -25.0614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6149 -24.2460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9142 -24.2357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8519 -23.9163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6737 -23.9134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9685 -23.1069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5707 -23.0993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2729 -22.6587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7912 -26.5545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6006 -23.3814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2333 -23.5083 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8708 -23.6958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6079 -25.0823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8252 -25.8696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6411 -25.9063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9281 -25.1416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2895 -24.6324 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0490 -26.1340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0956 -26.5948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8875 -25.4875 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
6.1500 -22.3792 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2 12 1 0
1 2 1 0
7 13 1 0
2 3 2 0
10 14 1 0
8 14 1 0
3 4 1 0
8 15 1 6
16 17 1 0
16 5 1 0
4 6 1 0
5 7 2 0
6 8 1 0
7 9 1 0
17 18 2 0
18 19 1 0
19 20 1 0
20 16 1 0
8 10 1 0
1 21 1 0
21 17 1 0
9 11 1 0
18 22 1 0
10 11 1 0
16 23 1 6
10 24 1 1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 302.46Molecular Weight (Monoisotopic): 302.2246AlogP: 5.11#Rotatable Bonds: ┄Polar Surface Area: 21.76Molecular Species: NEUTRALHBA: 2HBD: ┄#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.34CX LogD: 4.34Aromatic Rings: ┄Heavy Atoms: 22QED Weighted: 0.46Np Likeness Score: 3.33
References 1. Yu BZ, Kaimal R, Bai S, El Sayed KA, Tatulian SA, Apitz RJ, Jain MK, Deng R, Berg OG.. (2009) Effect of guggulsterone and cembranoids of Commiphora mukul on pancreatic phospholipase A(2): role in hypocholesterolemia., 72 (1): [PMID:19102680 ] [10.1021/np8004453 ] 2. Hassan HM, Sallam AA, Mohammed R, Hifnawy MS, Youssef DT, El Sayed KA.. (2011) Semisynthetic analogues of the marine cembranoid sarcophine as prostate and breast cancer migration inhibitors., 19 (16): [PMID:21775154 ] [10.1016/j.bmc.2011.06.060 ]